NeuroPace, Inc.
NPCE
$14.09
-$0.03-0.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 21.94% | 59.59% | -31.29% | -25.50% | 3.71% |
| Total Depreciation and Amortization | 7.19% | 2.10% | 3.25% | 2.44% | 0.00% |
| Total Amortization of Deferred Charges | -10.00% | 27.27% | 12.24% | 0.00% | 4.26% |
| Total Other Non-Cash Items | 1.76% | -32.34% | 32.79% | 0.41% | 10.18% |
| Change in Net Operating Assets | 96.23% | -179.84% | 147.88% | -45.60% | -647.81% |
| Cash from Operations | 126.03% | 6.81% | 72.12% | -55.97% | -178.25% |
| Capital Expenditure | -223.33% | 82.14% | -354.05% | 5.13% | 61.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 33.33% |
| Cash from Investing | -223.33% | 82.14% | -354.05% | -101.89% | 40.07% |
| Total Debt Issued | 100.00% | -100.23% | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -99.71% | 7,440.64% | -68.31% |
| Repurchase of Common Stock | 13.73% | 41.38% | 99.65% | -54,002.17% | -35.29% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 370.21% | 87.68% | -109.04% | 2,389.15% | -70.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 147.26% | 46.92% | -130.63% | 783.55% | -177.23% |